Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study

Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study

Abstract Background To investigate the effectiveness and safety of 3 mg drospirenone and 20 μg ethinyl estradiol tablet (3 mg DRSP/20 μg EE) in the treatment of polycystic ovary syndrome (PCOS). Methods This single center, prospective observational study was conducted in 140 patients with PCOS. They...

Full description

Bibliographic Details
Main Authors: Li Li, Ruiqin Zhang, Jing Zeng, Hu Ke, Xiuhong Peng, Liying Huang, Hongmei Zhang, Zhijing Chen, Tian Tian Li, Qiuxiao Tan, Ying Yang, Xiaofang Li, Xin Li
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Women's Health
Subjects:
Drospirenone
Ethinyl estradiol
PCOS
COC
Online Access:http://link.springer.com/article/10.1186/s12905-020-00905-x

Internet

http://link.springer.com/article/10.1186/s12905-020-00905-x

Similar Items